Indiplon in the management of insomnia

@inproceedings{Lemon2009IndiplonIT,
  title={Indiplon in the management of insomnia},
  author={Michael D Lemon and Joe D Strain and Annie M Hegg and Debra K Farver},
  booktitle={Drug design, development and therapy},
  year={2009}
}
Indiplon is a novel pyrazolopyrimidine, nonbenzodiazepine gamma-aminobutyric acid (GABA) agonist studied for the treatment of insomnia. This article reviews the chemistry, pharmacology, clinical pharmacokinetics, drug interactions, clinical trials, safety, tolerability, contraindications, use in special populations, and dosing of indiplon. OVID, International Pharmaceutical Abstracts (IPA), and PubMed databases were searched (1966 to February 2009) for the keywords indiplon, NBI-34060, and… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 41 references

Long-term use of indiplon in elderly patients with chronic insomnia [abstract

  • A Moscovitch, J Burke, R. Farber
  • 2006
Highly Influential
6 Excerpts

Treatment of primary insomnia for five weeks with indiplon-IR [abstract

  • JK Walsh, R Rosenberg, T Roth, DA Lankford, P. Jochelson
  • 2004
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…